Spots Global Cancer Trial Database for Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination
Official Title: Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination
Study ID: NCT02003508
Conditions
Interventions
Study Description
Brief Summary: This study will examine how common HPV infection is in teenage males in Australia before and after the introduction of universal school based vaccination of males in Australia.
Detailed Description: Males aged 17 to 19 in Australia will be recruited from 2014. Men will undergo sampling from the penis for HPV. The prevalence of HPV infection will be determined in 2014-2015 and compared to the prevalence in 2016-2017.
Eligibility
Minimum Age: 17 Years
Eligible Ages: CHILD, ADULT
Sex: MALE
Healthy Volunteers: Yes
Locations
Melbourne Sexual Health Centre, Melbourne, Victoria, Australia
Contact Details
Name: Marcus Y Chen, PhD
Affiliation: Melbourne Sexual Health Centre Alfred Health and Central Clinical School Monash University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
